486
Participants
Start Date
October 30, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2029
Tocilizumab
Single dose intravenous application
NaCl 0.9% 100ml
Single dose intravenous application
Shenzhen Second People's Hospital
OTHER
Central People's Hospital of Zhanjiang
OTHER
Shantou Central Hospital
OTHER
Eighth Affiliated Hospital, Sun Yat-sen University
OTHER
Guangzhou First People's Hospital
OTHER
Peking University Shenzhen Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
Zhujiang Hospital
OTHER